Brief: Preliminary Results On MDNA55 And MDNA109 To Be Presented At The Immuno-Oncology 360° Conference
24/01/2019 12:12
Jan 24 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* PRELIMINARY RESULTS ON MDNA55 AND MDNA109 TO BE PRESENTED
AT THE
IMMUNO-ONCOLOGY 360° CONFERENCE
Source text for Eikon: ID:nPn3mVcxta
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results